Drugs / Bifico
Bifico
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT01934959 | Jan 2008 → Jan 2010 | enterocolitis | Tongji Hospital | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04699721 | Jul 2020 → Sep 2027 expected | non-small cell lung carcinoma | Xiangya Hospital of Central South University | Active not recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03642548 | Feb 2019 → Mar 2024 | — | Shanghai 10th People's Hospital | Unknown | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT04131803 | Oct 2021 → Nov 2022 | colorectal cancer | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
| — | NCT05178524 | Jun 2021 → May 2022 | hepatocellular carcinoma | Tongji Hospital | Completed | No outcome recorded |
| — | NCT03379597 | Nov 2017 → May 2021 | bipolar disorder, schizophrenia | Central South University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifico | “as well as BiFico (oral taking, 4 capsules/time, 2 times per day)” NCT04699721 ↗ |
| Known as | bifidobacterium trifidum live powder | “Bifico (also known as "bifidobacterium trifidum live powder") is a probiotic preparation that has been marketed and widely used in China.” NCT04131803 ↗ |
| Known as | Bifidobacterium trifidum live powder (BiFico, SINE) | “Bifidobacterium trifidum live powder (BiFico, SINE)” NCT04699721 ↗ |
| Modality | Other / unclassified | “Bifico (also known as "bifidobacterium trifidum live powder") is a probiotic preparation” NCT04131803 ↗ |
| Route | Oral | “Bifico (Live combined bifidobacterium,Lactobacillus and Enterococcus capsules, Oral)” NCT03379597 ↗ |